US FDA’s Remote Evaluations Of Drug Manufacturing Facilities May Become Public

Agency is considering posting its observations from remote assessments of facilities, assistant commissioner Miller tells annual FDLI meeting; new FDA Inspectional Activities Council will develop an action plan for the agency’s inspections program.